GenSight Biologics. (SIGHT.PA) Q3 2024 Earnings

23SepConfirmed
Q4 2023
Q1 2024
Q1 2024
Q3 2024
-0.07
-0.04
-0.02
0

Details

Expected EPS
N/A
Actual EPS
-0.06747306216
Surprise EPS
-0.07
Surprise Percent
+∞%

Description

GenSight Biologics. (SIGHT.PA) has reported earnings of -0.06747306216 per share for Q3 2024.

0 Comments

Share your thoughts